Israeli medical tech company Q Core Medical, a developer of smart infusion systems for hospital and ambulatory care settings, announced the launch last week of new European headquarters in Marseille, France.
Q Core Medical develops, manufactures and markets advanced, future-ready infusion systems for ambulatory infusions in hospitals, treatments in homecare and alternate site settings. The company says its systems can be used in pain management, oncology drug delivery, epidural infusion, parenteral nutrition, and antibiotic treatments among other IV therapies.
Get our weekly newsletter directly in your inbox!Sign up
Q Core Medical is one of three affiliate companies by Netanya-based, medical devices company Eitan Group. The company also runs Sorrel Medical, a drug delivery platform, and Avoset Health, a drug delivery solutions company.
The new European regional headquarters for Q Core Medical will be run by Country Manager Laurent Schektman, who will lead direct sales efforts of Q Core’s hospital and homecare infusion systems in France and other European markets, the company said in a statement.
“It is a privilege to provide Q Core Medical’s advanced infusion systems to French and European healthcare facilities from our new office in Marseille, the doorway to the French and European healthcare markets,” said Schektman. “With a growing elderly population, an increased need for infusion, and a 5-10 percent increase in patients being treated in homecare settings rather than hospitals, France has a real market need for intuitive, easy-to-use and reliable infusion systems.”
Q Core Medical President Tally Eitan said: “We are delighted to directly market our pioneering infusion pump systems in France, expanding our physical footprint into such a vital regional market.”